Immune-related Adverse Events Associated with Cancer Immunotherapy: A Review for the Practicing[...]

In the context of the PRAISE e-cohort, we listed here scientific articles about OASI. This list is regularly updated.
Last update: January 29th, 2020
- Jun 13, 2019
Abatacept for Severe Immune Checkpoint Inhibitor–Associated Myocarditis
- Jan 24, 2019
Comparative effectiveness of rituximab, abatacept, and tocilizumab in adults with RA
- Aug 20, 2018
Impact of Baseline Steroids on Efficacy of Programmed CellDeath-1 and Programmed Death-Ligand 1 ...
- Jun 28, 2018
Biomarkers for Clinical Benefit of Immune Checkpoint Inhibitor Treatment-Review From the Mela [...]
- Mar 1, 2018
Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small-Cell Lung Cancer
- Feb 14, 2018
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint [...]
- May 4, 2016
Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination
- Feb 13, 2016
Diagnosis, monitoring and management of immune-related adverse drug reactions of anti-PD-1 [...]
- Feb 1, 2016
Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- Feb 1, 2016
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
- Dec 28, 2015
Management of immune checkpoint blockade dysimmune toxicities: a collaborative position paper
- Oct 7, 2015
Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of IRAEs [...]
- Jul 2, 2015
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma
- Mar 7, 2014
Endocrine-related adverse events following ipilimumab in patients with advanced melanoma [...]